Thermo Fisher Scientific (TMO)
EBITDA
$11.24B
TTM · Period ending: · USD
TMO EBITDA
Latest reported$11.24Bperiod ending
Latest reported$11.24Bperiod ending
TMO TTM EBITDA ($12.40M → $11.24B)
TTM EBITDA
High-resolution chart · PNG
TMO ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| 266,379,000 | |
| 262,017,000 | |
| 277,436,000 | |
| 276,500,000 | |
| 222,087,000 | |
| 257,737,000 | |
| 286,103,000 | |
| 291,031,000 | |
| 401,031,000 | |
| 448,093,000 | |
| 487,856,000 | |
| 539,800,000 | |
| 575,600,000 | |
| 585,900,000 | |
| 538,300,000 | |
| 506,500,000 | |
| 436,900,000 | |
| 362,600,000 | |
| 326,300,000 | |
| 284,400,000 | |
| 271,000,000 | |
| 261,300,000 | |
| 256,900,000 | |
| 247,400,000 | |
| 226,900,000 | |
| 205,400,000 | |
| 190,500,000 | |
| 180,000,000 | |
| 164,600,000 | |
| 157,300,000 | |
| 138,000,000 | |
| 137,800,000 | |
| 118,400,000 | |
| 102,800,000 | |
| 96,300,000 | |
| 68,300,000 | |
| 58,800,000 | |
| 43,900,000 | |
| 36,200,000 | |
| 36,700,000 | |
| 41,500,000 | |
| 45,900,000 | |
| 43,200,000 | |
| 43,300,000 | |
| 36,400,000 | |
| 29,100,000 | |
| 173,300,000 | |
| 301,200,000 | |
| -36,900,000 | |
| 82,500,000 | |
| 53,100,000 | |
| 19,100,000 | |
| 52,700,000 | |
| 36,200,000 | |
| 10,300,000 | |
| 300,000 | |
| 67,000,000 | |
| 43,100,000 | |
| 27,300,000 | |
| 12,400,000 | |
| 51,800,000 | |
| 29,700,000 |